Inventor

Arthur A. Patchett

Inventor

Westfield, NJ, US

Overview

1976–2009

Patent span

Chemistry

Primary field (CPC C)

Patents· 136 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds31%

A61KPreparations for medical, dental or toiletry purposes22%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%

C07KPeptides14%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%

C07CAcyclic or carbocyclic compounds3%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%

Y02PClimate change mitigation technologies in the production or processing of goods1%

B82YSpecific uses or applications of nanostructures1%

A01NPreservation of bodies of humans or animals or plants or parts thereof0%

PatentTitleYear

7,504,425'Compounds useful in the treatment of anthrax and inhibiting lethal factor'2009 7,179,886'Cloning and identification of the motilin receptor'2007 6,767,915'Substituted piperidines as melanocortin receptor agonists'2004 6,552,043'Benzimidazolinyl piperidines as CGRP ligands'2003 6,420,376'Amido spiropiperidines promote the release of growth hormone'2002 6,410,548'Spiropiperidine derivatives as melanocortin receptor agonists'2002 6,387,932'Somatostatin agonists'2002 6,350,760'Substituted piperidines as melanocortin-4 receptor agonists'2002 6,294,534'Spiropiperidine derivatives as melanocortin receptor agonists'2001 6,121,325'Naphthyl compounds promote release of growth hormone'2000 6,117,880'Somatostatin agonists'2000 6,090,836'Benzisoxazole-derived antidiabetic compounds'2000 6,063,796'Somatostatin agonists'2000 6,057,338'Somatostatin agonists'2000 6,043,026'Combination therapy for the prevention and treatment of osteoporosis'2000 6,025,372'Somatostatin agonists'2000 6,020,382'Method of treating diabetes and related disease states'2000 5,965,565'Piperidines promote release of growth hormone'1999 5,925,659'Antibacterial agents'1999 5,877,182'Piperidines promote release of growth hormone'1999 5,847,008'Method of treating diabetes and related disease states'1998 5,804,578'Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone'1998 5,783,582'Piperidines and hexahydro-1H-azepines spiro substituted at the 4-position promote release of growth hormone'1998 5,777,112'Piperazine compounds promote release of growth hormone'1998 5,767,118'4-Heterocyclic peperidines promote release of growth hormone'1998 5,731,317'Bridged piperidines promote release of growth hormone'1998 5,721,251'Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone'1998 5,721,250'Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone'1998 5,663,171'Acyclic compounds promote release of growth hormone'1997 5,656,606'Camphor compounds promote release of growth hormone'1997 5,652,235'Method of using spiro piperidines to promote the release of growth hormone'1997 5,622,973'Treatment of osteoporosis with substituted piperidines, pyrrolidines and hexahydro-1H-azepines in combination with bisphosphonates'1997 5,578,593'Spiro piperidines and homologs promote release of growth hormone'1996 5,559,128'3-substituted piperidines promote release of growth hormone'1996 5,547,978'Derivatives of pyrrolidin-2-ylcarbonylheterocyclic compounds'1996 5,536,716'Spiro piperidines and homologs which promote release of growth hormone'1996 5,494,919'2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone'1996 5,492,916'Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone'1996 5,492,920'Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone'1996 5,449,682'Angiotensin II antagonists incorporating a substituted benzyl element'1995 5,441,959'Substituted quinazolinones bearing acidic functional groups as angiotensin II antagonists'1995 5,412,097'Heterocyclic compounds bearing acidic functional groups as angiotensin II antagonists'1995 5,411,980'Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists'1995 5,389,660'Substituted imidazo-fused 5-membered ring heterocycles as angiotensin II antagonists'1995 5,385,894'Disubstituted 6-aminoquinazolinones'1995 5,336,778'Substituted triazoles as angiotensin II antagonists'1994 5,332,744'Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists'1994 5,330,987'Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists'1994 5,324,729'Substituted pyrimidines, pyrimidinones and pyridopyrimidines'1994 5,318,901'Method for the production of a modified \"8-amino acid\" cyclosporin derivative'1994 5,281,614'Substituted 1,2,4-triazoles bearing acidic functional groups as angiotensin II antagonists'1994 5,264,439'Quinazolinone, triazolinone and pyrimidinone angiotensin II antagonists incorporating a substituted benzyl element'1993 5,260,285'Substituted imidazopyridazines as angiotensin II antagonists'1993 5,254,682'Cyclic renin inhibitors containing 3(S)-amino-4-cyclohexyl-2(R)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2R, 3S)-dihydroxybutanoic acid or related analogs'1993 5,250,521'Substituted pyrazolopyrimidines as angiotensin II antagonists'1993 5,240,928'Substituted quinazolinones as angiotensin II antagonists'1993 5,240,938'Angiotensin II antagonists incorporating a substituted pyridoimidazolyl ring'1993 5,238,942'Substituted quinazolinones bearing acidic functional groups as angiotensin II antagonists'1993 5,236,928'Imidazole derivatives bearing acidic functional groups at the 5-position, their compositions and methods of use as angiotensin II antagonists'1993 5,223,501'Substituted pyrimidinones bearing acidic functional groups as angiotensin II antagonists'1993 5,214,130'Synthesis of novel immunosuppressive cyclosporin analogs with modified amino acids at position-8'1993 5,202,328'Substituted fused pyrimidinones'1993 5,183,810'Imidazole angiotensin II antagonists incorporating a substituted benzyl element'1993 5,177,095'Triazole angiotensin II antagonists incorporating a substituted benzyl element'1993 5,175,164'Angiotensin II antagonists incorporating a substituted indole or dihydroindole'1992 5,166,206'Substituted pyrimidines, pyrimidinones and pyridopyrimidines'1992 5,164,407'Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin II antagonsists'1992 5,162,340'Substituted 1-(2H)-isoquinolinones bearing acidic functional groups as angiotensin II antagonists'1992 5,157,026'Oxo-purines as angiotensin II antagonists'1992 5,151,435'Angiotensin II antagonists incorporating an indole or dihydroindole'1992 5,151,521'1-aminoethyl phosphonic acid derivatives'1992 5,147,867'Phosphorus containing enzyme inhibitors'1992 5,145,990'Phosphorous containing dhp enzyme inhibitors'1992 5,143,908'Antibacterial agents and potentiators of carbapenem antibiotics'1992 5,141,954'Antifungal carbazate'1992 5,126,342'Imidazole angiotensin II antagonists incorporating acidic functional groups'1992 5,124,335'Substituted pyrollo-fused 6 membered heterocycles as angiotensin II antagonists'1992 5,122,511'Immunosuppressive cyclosporin analogs with modified amino acids at position-8'1992 5,102,880'Substituted imidazo-fused 6-membered heterocycles as angiotensin II antagonists'1992 5,100,897'Substituted pyrimidinones as angiotensin II antagonists'1992 5,099,063'Certain phosphinic acid derivatives having antibacterial activity'1992 5,064,825'Angiotensin II antagonists'1991 5,061,806'Phosphinic acid derivatives'1991 5,039,664'Renin inhibitors containing phenylalanyl-histidine replacements'1991 5,037,807'Renin inhibitors containing phenylalanyl-histidine replacements'1991 4,962,097'Method of treating bacterial infection with phosphorus containing DHP enzyme inhibitors'1990 4,921,844'Fungicidal compositions and method'1990 4,920,113'Fungicidal compositions and methods utilizing 25-azasterol and HMG-CoA synthase inhibitors'1990 4,920,112'Fungicidal compositions and method'1990 4,920,111'Fungicidal compositions and methods utilizing 25-azasterol and HMG-CoA reductase inhibitors'1990 4,920,109'Antifungal compositions and method of controlling mycotic infections'1990 4,873,235'Benzofused lactams as antihypertensives'1989 4,866,087'Carboxyalkyl urea compounds and derivatives thereof useful as angiotensin converting enzyme inhibitors and as antihypertensives'1989 4,839,357'Renin inhibitors containing phenylalanyl-histidine replacements'1989 4,751,237'Antihypercholesterolemic beta-lactones'1988 4,727,062'3-Halovinylglycine antibacterial agents'1988 4,715,994'Novel antibacterial agents and potentiators of carbapenem antibiotics'1987 4,695,588'Fluorinated amino acids'1987 4,692,522'Benzofused lactams useful as cholecystokinin antagonists'1987 4,680,392'Substituted caprolactam derivatives as antihypertensives'1987 4,661,479'Bicyclic lactams as antihypertensives'1987 4,659,720'5-amino or substituted amino imidazoles useful to treat coccidiosis'1987 4,629,787'Substituted caprolactam derivatives as antihypertensives'1986 4,617,301'Sulfoxide and sulfone derivatives of bicyclic lactams as antihypertensives'1986 4,602,002'N-carboxymethyl substituted lysyl and .alpha.-(.epsilon.-aminoalkyl) glycyl amino acid antihypertensive agents'1986 4,594,341'Perhydro-1,4-thiazepin-5-one and perhydro-1,4-thiazocin-5-one derivatives as antihypertensives'1986 4,587,050'Substituted enantholactam derivatives as antihypertensives'1986 4,587,238'Substituted caprylolactam derivatives as anti-hypertensives'1986 4,576,748'3-Hydroxy-3-aminoethyl .beta.-lactams'1986 4,555,503'N.sup.2 -(Substituted)carboxymethyl-N.sup.6 -(substituted)-lysyl-and .alpha..epsilon.-aminoalkyl)glycyl amino acid antihypertensive agents'1985 4,555,502'Aminoacyl-containing dipeptide derivatives useful as antihypertensives'1985 4,512,979'Dipeptides containing thialysine and related amino acids as antihypertensives'1985 4,483,870'.alpha.-Difluoromethyl amino acids and hypertension treating compositions thereof'1984 4,483,850'N-Terminal substituted oligopeptide converting enzyme inhibitors'1984 4,472,380'Amino acid derivatives as antihypertensives'1984 4,431,821'Fluorinated tryptamines'1984 4,431,817'Fluorinated imidazolyl alkylamines'1984 4,423,063'2,4-Dioxo-4-substituted-1-butaoic acid derivatives useful in treating urinary track calcium oxalate lithiasis'1983 4,415,496'Bicyclic lactams'1983 4,402,969'Antihypertensive proline derivatives'1983 4,401,676'Novel .alpha.-amino acids'1983 4,379,146'Substituted phosphonamides as antihypertensives'1983 4,374,829'Aminoacid derivatives as antihypertensives'1983 4,360,533'Glyceryl ester of 1-methyl-2-(3,4-dihydroxyphenyl)alanine'1982 4,351,844'Hypocholesterolemic hydrogenation products and process of preparation'1982 4,347,375'Process for preparing amino acids and esters'1982 4,339,453'Antimicrobial aminopyrimidinium salts'1982 4,337,258'2,4-Dioxo-4-substituted-1-butanoic acid derivatives useful in treating urinary tract calcium oxalate lithiasis'1982 4,336,397'2,4-Dioxo-4-substituted-1-butanoic acid derivatives useful in treating urinary tract calcium oxalate lithiasis'1982 4,325,961'Fluorinated amino acids'1982 4,316,896'Aminoacid derivatives as antihypertensives'1982 4,275,220'Process for preparing amino acids and esters'1981 4,070,360'4,9-Diazatricyclo[6.2.2.0.sup.2,7 ]dodec-11-enes'1978 4,070,359'Process for preparing 5,11-diazatetracyclododecanes'1978 4,033,968'Diazatetracyclododecanes'1977 3,991,185'Methods for treating coccidiosis with emimycin and its derivatives'1976

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1976–2009Patents assigned to MERCK & CO INC (135)· patent assignee history

1976–1987Based in Cranford, NJ, US· patent location history

1981–2009Based in Westfield, NJ, US· patent location history

1992Based in Scotch Plains, NJ, US· patent location history

1996Patents assigned to MEIJI SEIKA KAISHA (1)· patent assignee history

2003Patents assigned to MERCK SHARPE & DOHME LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
MERCK & CO INC	135	1976–2009
MEIJI SEIKA KAISHA	1	1996
MERCK SHARPE & DOHME LTD	1	2003

Locations

Location	Patents	Span
Westfield, New Jersey, US	126	1981–2009
Cranford, New Jersey, US	9	1976–1987
Scotch Plains, New Jersey, US	1	1992